Purchases and Sales Made in Q3 2022 in Summit Therapeutics Inc. (SMMT)
This table provides information about the institutional ownership of Summit Therapeutics Inc. (SMMT) during Q3 2022. The information is specifically focused on institutions that hold shares of Summit Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
270K+ 496.62% |
$240K - $440K
|
324K
$6.52M
|
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
142K+ 67.95% |
$127K - $232K
|
351K
$7.07M
|
|
|
Nov 14, 2022
Q3 2022
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
141KNew |
$125K - $229K
|
141K
$2.83M
|
|
|
Nov 14, 2022
Q3 2022
|
Black Rock Inc.
New York, NY |
BUY
|
- |
119K+ 39.34% |
$106K - $194K
|
421K
$8.47M
|
|
|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
58.1K+ 245.67% |
$51.7K - $94.7K
|
81.7K
$1.64M
|
|
|
Nov 14, 2022
Q3 2022
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
29.8K+ 280.89% |
$26.5K - $48.5K
|
40.4K
$812K
|
|
|
Nov 10, 2022
Q3 2022
|
Bank Of Montreal
Toronto, A6 |
BUY
|
- |
28.5KNew |
$25.4K - $46.5K
|
28.5K
$573K
|
|
|
May 14, 2024
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
26.3K+ 76.61% |
$23.4K - $42.9K
|
60.7K
$1.22M
|
|
|
Nov 10, 2022
Q3 2022
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
26.3K+ 76.61% |
$23.4K - $42.9K
|
60.7K
$1.22M
|
|
|
Nov 09, 2022
Q3 2022
|
Group One Trading, L.P.
Chicago, IL |
BUY
|
- |
24.7KNew |
$22K - $40.3K
|
24.7K
$497K
|
|
|
Nov 14, 2022
Q3 2022
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
22.9KNew |
$20.4K - $37.3K
|
22.9K
$461K
|
|
|
Nov 14, 2022
Q3 2022
|
Jane Street Group, LLC
New York, NY |
BUY
|
- |
20.3KNew |
$18K - $33K
|
20.3K
$407K
|
|
|
Nov 14, 2022
Q3 2022
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
17.1KNew |
$15.2K - $27.9K
|
17.1K
$344K
|
|
|
Nov 04, 2022
Q3 2022
|
Pro Share Advisors LLC
|
BUY
|
- |
16.9KNew |
$15.1K - $27.6K
|
16.9K
$340K
|
|
|
Nov 14, 2022
Q3 2022
|
Man Group PLC
London, X0 |
BUY
|
- |
15.7KNew |
$14K - $25.6K
|
15.7K
$316K
|
|
|
Nov 14, 2022
Q3 2022
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
7.26K+ 141.32% |
$6.46K - $11.8K
|
12.4K
$249K
|
|
|
Nov 14, 2022
Q3 2022
|
Osterweis Capital Management Inc
San Francisco, CA |
BUY
|
- |
5KNew |
$4.45K - $8.15K
|
5K
$101K
|
|
|
Nov 07, 2022
Q3 2022
|
Evoke Wealth, LLC
|
BUY
|
- |
3K+ 60.0% |
$2.67K - $4.89K
|
8K
$161K
|
|
|
Nov 15, 2022
Q3 2022
|
Mercer Global Advisors Inc
Denver, CO |
BUY
|
- |
2.1K+ 5.22% |
$1.87K - $3.42K
|
42.3K
$851K
|
|
|
Nov 10, 2022
Q3 2022
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
2.03K+ 21.66% |
$1.8K - $3.31K
|
11.4K
$229K
|
|
|
Oct 21, 2022
Q3 2022
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
BUY
|
- |
1.89KNew |
$1.68K - $3.07K
|
1.89K
$37.9K
|
|
|
Nov 14, 2022
Q3 2022
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
1.48K+ 717.48% |
$1.32K - $2.41K
|
1.68K
$33.9K
|
|
|
Nov 03, 2022
Q3 2022
|
Barclays PLC
London, X0 |
BUY
|
- |
961+ 85.2% |
$855 - $1.57K
|
2.09K
$42K
|
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
BUY
|
- |
829+ 48.2% |
$738 - $1.35K
|
2.55K
$51.3K
|
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
200+ 0.96% |
$178 - $326
|
21.1K
$424K
|
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2022
Q3 2022
|
Cowen And Company, LLC
|
SELL
|
- |
-800- 4.43% |
$712 - $1.3K
|
17.2K
$347K
|
|
|
Nov 14, 2022
Q3 2022
|
Qube Research & Technologies LTD
London, X0 |
SELL
|
- |
-1.69K- 8.99% |
$1.5K - $2.76K
|
17.1K
$344K
|
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-14.1K- 22.25% |
$12.5K - $23K
|
49.2K
$990K
|
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-25.9K- 5.66% |
$23.1K - $42.2K
|
432K
$8.68M
|